Racemetirosine | CAS#658-48-0 | Tyrosine-3-monooxygenase inhibitor

MedKoo Cat#: 592670 | Name: Racemetirosine

Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Racemetirosine is an inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines.

Chemical Structure

Racemetirosine

CAS#658-48-0

Theoretical Analysis

MedKoo Cat#: 592670

Name: Racemetirosine

CAS#: 658-48-0

Chemical Formula: C10H13NO3

Exact Mass: 195.0895

Molecular Weight: 195.22

Elemental Analysis: C, 61.53; H, 6.71; N, 7.18; O, 24.59

Price and Availability

Size	Price	Availability	Quantity
1g	USD 250.00	2 Weeks
5g	USD 450.00	2 Weeks

Bulk Inquiry

Buy Now

Add to Cart

Related CAS #

No Data

Synonym

DL-2-Methyl-3-(4-hydroxyphenyl)alanine; AMPT, α-Methyl-DL-tyrosine; Racemetirosine

IUPAC/Chemical Name

2-amino-3-(4-hydroxyphenyl)-2-methylpropanoic acid

InChi Key

NHTGHBARYWONDQ-UHFFFAOYSA-N

InChi Code

InChI=1S/C10H13NO3/c1-10(11,9(13)14)6-7-2-4-8(12)5-3-7/h2-5,12H,6,11H2,1H3,(H,13,14)

SMILES Code

CC(CC1=CC=C(C=C1)O)(C(O)=O)N

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.03.00

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 195.22 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Ljungström M, Oltra E, Pardo M. Stress-Related Chronic Fatigue Syndrome: A Case Report with a Positive Response to Alpha-Methyl-P-Tyrosine (AMPT) Treatment. Int J Mol Sci. 2024 Jul 16;25(14):7778. doi: 10.3390/ijms25147778. PMID: 39063020; PMCID: PMC11276651. 2: Yi LX, Tan EK, Zhou ZD. Tyrosine Hydroxylase Inhibitors and Dopamine Receptor Agonists Combination Therapy for Parkinson's Disease. Int J Mol Sci. 2024 Apr 24;25(9):4643. doi: 10.3390/ijms25094643. PMID: 38731862; PMCID: PMC11083272. 3: Ohmachi Y, Yamamoto M, Inaba Y, Makino S, Urai S, Matsumoto R, Bando H, Kanie K, Tsujimoto Y, Motomura Y, Sasaki Y, Oi-Yo Y, Yamamoto N, Suzuki M, Takahashi M, Iguchi G, Kanzawa M, Furukawa J, Shigemura K, Mizobuchi S, Ogawa W, Fukuoka H. The combination of doxazosin and metyrosine as a preoperative treatment for pheochromocytomas and paragangliomas. Endocrine. 2024 May;84(2):694-703. doi: 10.1007/s12020-023-03681-4. Epub 2024 Jan 11. PMID: 38206436. 4: Woodman R, Miller C, Student J, Freeman K, Perl D, Lockette W. Alpha- methyltyrosine reduces the acute cardiovascular and behavioral sequelae in a murine model of traumatic brain injury. J Trauma Acute Care Surg. 2023 Oct 1;95(4):542-548. doi: 10.1097/TA.0000000000004023. Epub 2023 May 11. PMID: 37165479; PMCID: PMC10545058. 5: Yapca OE, Yildiz GA, Mammadov R, Kurt N, Gundogdu B, Arslan YK, Suleyman H, Cetin N. The effects of metyrosine on ischemia-reperfusion-induced oxidative ovarian injury in rats: Biochemical and histopathological assessment. An Acad Bras Cienc. 2023 Apr 3;95(2):e20201586. doi: 10.1590/0001-3765202320201586. PMID: 37018835. 6: Hibicke M, Nichols CD. Validation of the forced swim test in Drosophila, and its use to demonstrate psilocybin has long-lasting antidepressant-like effects in flies. Sci Rep. 2022 Jun 15;12(1):10019. doi: 10.1038/s41598-022-14165-2. PMID: 35705666; PMCID: PMC9200711. 7: Voronkov D, Stavrovskaya A, Olshanskiy A, Guschina A, Khudoerkov R, Illarioshkin S. The Influence of Striatal Astrocyte Dysfunction on Locomotor Activity in Dopamine-depleted Rats. Basic Clin Neurosci. 2021 Nov- Dec;12(6):767-776. doi: 10.32598/bcn.2021.1923.1. Epub 2021 Nov 1. PMID: 35693141; PMCID: PMC9168813. 8: Kim A, Pavlova E, Kolacheva A, Bogdanov V, Dilmukhametova L, Blokhin V, Valuev L, Valuev I, Gorshkova M, Ugrumov M. Development of early diagnosis of Parkinson's disease on animal models based on the intranasal administration of α-methyl-p-tyrosine methyl ester in a gel system. Biomed Pharmacother. 2022 Jun;150:112944. doi: 10.1016/j.biopha.2022.112944. Epub 2022 Apr 9. PMID: 35405394. 9: Kanai A, Hanaoka H, Yamaguchi A, Mahendra I, Palangka C, Ohshima Y, Higuchi T, Tsushima Y. Enhancing the accumulation level of 3-[18F]fluoro-L-α- methyltyrosine in tumors by preloading probenecid. Nucl Med Biol. 2022 Jan- Feb;104-105:47-52. doi: 10.1016/j.nucmedbio.2021.11.006. Epub 2021 Dec 3. PMID: 34896813. 10: Raupp-Barcaro IFM, da Silva Dias IC, Meyer E, Vieira JCF, da Silva Pereira G, Petkowicz AR, de Oliveira RMW, Andreatini R. Involvement of dopamine D2 and glutamate NMDA receptors in the antidepressant-like effect of amantadine in mice. Behav Brain Res. 2021 Sep 10;413:113443. doi: 10.1016/j.bbr.2021.113443. Epub 2021 Jul 1. PMID: 34216648. 11: Turan Yücel N, Kandemir Ü, Demir Özkay Ü, Can ÖD. 5-HT1A Serotonergic, α-Adrenergic and Opioidergic Receptors Mediate the Analgesic Efficacy of Vortioxetine in Mice. Molecules. 2021 May 28;26(11):3242. doi: 10.3390/molecules26113242. PMID: 34071269; PMCID: PMC8199248. 12: Idalencio R, Lopes TM, Soares SM, Pompermaier A, de Alcantara Barcellos HH, Kalichak F, Fagundes M, de Oliveira CM, Barcellos LJG. Effect of levodopa/carbidopa on stress response in zebrafish. J Comp Physiol A Neuroethol Sens Neural Behav Physiol. 2021 May;207(3):393-399. doi: 10.1007/s00359-021-01479-1. Epub 2021 Mar 27. PMID: 33772638. 13: Gruber LM, Jasim S, Ducharme-Smith A, Weingarten T, Young WF, Bancos I. The Role for Metyrosine in the Treatment of Patients With Pheochromocytoma and Paraganglioma. J Clin Endocrinol Metab. 2021 May 13;106(6):e2393-e2401. doi: 10.1210/clinem/dgab130. PMID: 33693908; PMCID: PMC8118583. 14: Zhang DM, Chen SL. Cytokine storms caused by novel coronavirus 2019 and treatment for cardiac injury. Eur Rev Med Pharmacol Sci. 2020 Dec;24(23):12527-12535. doi: 10.26355/eurrev_202012_24050. PMID: 33336773. 15: Kaneda-Nakashima K, Zhang Z, Manabe Y, Shimoyama A, Kabayama K, Watabe T, Kanai Y, Ooe K, Toyoshima A, Shirakami Y, Yoshimura T, Fukuda M, Hatazawa J, Nakano T, Fukase K, Shinohara A. α-Emitting cancer therapy using 211 At-AAMT targeting LAT1. Cancer Sci. 2021 Mar;112(3):1132-1140. doi: 10.1111/cas.14761. Epub 2021 Jan 22. PMID: 33277750; PMCID: PMC7935802. 16: Fang F, Ding L, He Q, Liu M. Preoperative Management of Pheochromocytoma and Paraganglioma. Front Endocrinol (Lausanne). 2020 Sep 29;11:586795. doi: 10.3389/fendo.2020.586795. PMID: 33117294; PMCID: PMC7551102. 17: Jin C, Wei L, Ohgaki R, Tominaga H, Xu M, Okuda S, Okanishi H, Kawamoto Y, He X, Nagamori S, Kanai Y. Interaction of Halogenated Tyrosine/Phenylalanine Derivatives with Organic Anion Transporter 1 in the Renal Handling of Tumor Imaging Probes. J Pharmacol Exp Ther. 2020 Dec;375(3):451-462. doi: 10.1124/jpet.120.000235. Epub 2020 Sep 27. PMID: 32981893. 18: Turgeon SM, Abdulzahir A, Hwang K, Sanford J. Pharmacological depletion of serotonin and norepinephrine with para-chlorophenylalanine and alpha-methyl-p- tyrosine reverses the antidepressant-like effects of adolescent caffeine exposure in the male rat. Behav Pharmacol. 2020 Dec;31(8):768-775. doi: 10.1097/FBP.0000000000000588. PMID: 32897889. 19: Hao Z, Li R, Meng L, Han Z, Hong Z. Macrophage, the potential key mediator in CAR-T related CRS. Exp Hematol Oncol. 2020 Jul 10;9:15. doi: 10.1186/s40164-020-00171-5. PMID: 32665874; PMCID: PMC7349474. 20: Kuriyama K, Higuchi T, Yokobori T, Saito H, Yoshida T, Hara K, Suzuki S, Sakai M, Sohda M, Higuchi T, Tsushima Y, Asao T, Kaira K, Kuwano H, Shirabe K, Saeki H. Uptake of positron emission tomography tracers reflects the tumor immune status in esophageal squamous cell carcinoma. Cancer Sci. 2020 Jun;111(6):1969-1978. doi: 10.1111/cas.14421. Epub 2020 May 12. PMID: 32302443; PMCID: PMC7293073.